Cambridge Investment Research Advisors’s PIMCO Commodity Strategy Active Exchange-Traded Fund CMDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.45M Buy
199,792
+29,206
+17% +$871K 0.02% 822
2025
Q4
$4.71M Buy
170,586
+2,700
+2% +$74.5K 0.01% 971
2025
Q3
$4.6M Buy
167,886
+11,446
+7% +$303K 0.01% 964
2025
Q2
$4.04M Buy
156,440
+573
+0.4% +$14.7K 0.01% 966
2025
Q1
$4.17M Buy
155,867
+75,711
+94% +$1.99M 0.01% 894
2024
Q4
$2.02M Buy
80,156
+7,192
+10% +$187K 0.01% 1350
2024
Q3
$1.95M Buy
72,964
+11,042
+18% +$290K 0.01% 1368
2024
Q2
$1.69M Buy
61,922
+30,197
+95% +$826K 0.01% 1408
2024
Q1
$861K Buy
+31,725
New +$832K ﹤0.01% 1832

Other funds holding CMDT

Cambridge Investment Research Advisors's CMDT Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its PIMCO Commodity Strategy Active Exchange-Traded Fund (CMDT) stake by 17% in Q1 2026, buying an estimated $871K and bringing the position to 199,792 shares worth $6.45M. The position accounts for 0.02% of the portfolio, ranked #822.

Cambridge Investment Research Advisors first reported a position in CMDT in Q1 2024 and has held it in 9 quarters since. 54 funds tracked by Wall St. Rank hold CMDT as of Q1 2026.

  • Cambridge Investment Research Advisors held 199,792 shares of PIMCO Commodity Strategy Active Exchange-Traded Fund worth $6.45M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 29,206 PIMCO Commodity Strategy Active Exchange-Traded Fund shares in Q1 2026, an estimated $871K.
  • PIMCO Commodity Strategy Active Exchange-Traded Fund made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #822 holding.
  • Cambridge Investment Research Advisors first reported a position in PIMCO Commodity Strategy Active Exchange-Traded Fund in Q1 2024 and has held it in 9 quarters since.
  • 54 funds tracked by Wall St. Rank held PIMCO Commodity Strategy Active Exchange-Traded Fund as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.